Codexis to share RNA manufacturing advances at TIDES USA
April 29, 2026
Diffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523
December 1, 2021
Related Post
-
-
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
April 28, 2026
-
NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer
April 27, 2026
-
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
April 27, 2026